Exploring Clever Leaves Holdings Inc. (CLVR) Investor Profile: Who’s Buying and Why?

Exploring Clever Leaves Holdings Inc. (CLVR) Investor Profile: Who’s Buying and Why?

US | Healthcare | Drug Manufacturers - Specialty & Generic | NASDAQ

Clever Leaves Holdings Inc. (CLVR) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

You're looking at Clever Leaves Holdings Inc. (CLVR), a stock that's less about institutional stability and more about high-risk concentration, and the investor profile confirms it's a micro-cap tightrope walk. Honestly, the first thing you notice is the size: a tiny market capitalization of just $175,000 as of October 2025, with only about 1.75 million shares outstanding. This isn't a BlackRock-style holding; it's a micro-cap play where the general public holds a staggering 81.1% of the company. But here's the real kicker: one single hedge fund, BSWM Gestão de Recursos Ltda., controls a massive 18.4% of the shares, totaling 322,236 shares. That level of concentration means one big player's move can defintely swing the price, especially when traditional institutions own a negligible 0.284%. Are you prepared to invest alongside a single, dominant hedge fund in a company that just reported its Q3 2025 earnings, and what does that extreme ownership skew tell you about the stock's liquidity and future direction?

Who Invests in Clever Leaves Holdings Inc. (CLVR) and Why?

You're looking at Clever Leaves Holdings Inc. (CLVR) and trying to figure out who's buying this stock and what their endgame is. The direct takeaway is that this company's investor base is highly concentrated and driven by a mix of long-term, conviction-based institutional money and a large, speculative retail float. The key attraction is the firm's low-cost, pharmaceutical-grade production model, which is finally showing a path to profitability in a volatile sector.

The ownership structure is not typical of a large-cap stock. As of late 2025, the General Public (or retail investors) holds the vast majority of shares, but a single hedge fund controls a significant block. It's a classic setup for high volatility, so you need to understand the players before you commit capital. The stock is thinly traded on the OTC market, which amplifies price swings defintely.

Here is the quick breakdown of the investor types, based on recent filings and data:

Investor Type Approximate Ownership Percentage Key Entity Example
General Public (Retail) 81.1% Individual Investors
Hedge Funds 18.4% BSWM Gestão de Recursos Ltda.
Institutional Investors 0.284% Tidal Investments LLC
Individual Insiders 0.212% Henry Hague (CFO)

Investment Motivations: The Low-Cost, Global Play

The core motivation for investors is Clever Leaves Holdings Inc.'s unique position as a multinational operator leveraging low-cost production in Colombia to supply high-value, pharmaceutical-grade cannabis products to regulated international markets. This isn't a US recreational cannabis play; it's a global B2B supplier.

Investors are betting on two main factors: cost advantage and market expansion. The company's focus on key markets like Germany, Australia, Brazil, Israel, and the United Kingdom is a clear signal of their strategy. They are aiming to be the low-cost supplier of active pharmaceutical ingredients (APIs) and finished products in these high-margin, regulated jurisdictions. This is a long-term structural bet on the global medical cannabis supply chain.

The recent financial performance provides a concrete anchor for this thesis. The company is forecasting fiscal year 2025 net revenue to be within the range of $290 to $293 million, with an Adjusted EBITDA margin outlook of approximately 8% to 9%. This push toward positive cash flow and margin expansion is a huge draw for institutional money that prioritizes financial discipline over pure revenue growth. In Q3 2025, they even reported a net income of $6.4 million, although this was largely driven by a $5.8 million gain on debt extinguishment, still, it shows aggressive balance sheet management. Plus, debt outstanding is down $65.0 million year-over-year, which is a big de-risking move.

  • Betting on low-cost production in Colombia.
  • Targeting high-margin, regulated global markets.
  • Looking for financial stability and margin growth.

Strategies: Conviction, Speculation, and Volatility

The investment strategies seen in Clever Leaves Holdings Inc.'s stock are sharply divided, reflecting the ownership split. For the one major hedge fund, holding 18.4% of the company, the strategy is a high-conviction, long-term position. They see a deep-value opportunity in the firm's assets and its strategic Mission Statement, Vision, & Core Values of Clever Leaves Holdings Inc. (CLVR)., which emphasizes quality and compliance.

This type of investor is typically a Value Investor or a Long-Term Holder, waiting for the global regulatory environment to mature and for the company to fully realize its cost advantages and market access. Their patience is tied to the belief that the low-cost model will eventually translate into significant, sustainable earnings.

On the flip side, the large 81.1% retail float often engages in Short-Term Trading and Speculation. This is common for thinly traded stocks in nascent, high-growth sectors like cannabis. The stock is known for 'wild speculative swings,' with price movements often disconnected from fundamental news. This extreme volatility attracts traders looking to capitalize on momentum and short-term price dislocations rather than the company's five-year outlook. You see huge percentage moves that are purely technical. The low institutional float means there's less of a stabilizing force, so a small amount of trading volume can send the price soaring or collapsing.

  • Hedge funds are taking a conviction-based, value approach.
  • Retail investors are driving short-term, speculative trading.

What this estimate hides is that the high retail ownership means sentiment is a massive driver. If a new market opens up, the stock can jump fast. If a financing deal dilutes shareholders, it can crash just as quickly. Your action should be to draft a sensitivity analysis on your valuation, mapping a 10% change in the $290 million revenue forecast to the share price by next Friday.

Institutional Ownership and Major Shareholders of Clever Leaves Holdings Inc. (CLVR)

You need to know who is really behind Clever Leaves Holdings Inc. (CLVR) because the investor profile tells you everything about the company's risk and future strategy. The short answer is that institutional ownership is highly concentrated and relatively low for a former Nasdaq-listed company, sitting around 18.86% among the top three shareholders, which is a major factor in the stock's current volatility.

As of late 2025, the ownership structure of Clever Leaves Holdings Inc. is dominated by a single large hedge fund stake, with the rest largely held by the general public. This is not the typical profile of a well-capitalized, exchange-listed firm, but it's common for companies trading Over-The-Counter (OTC) following a delisting.

Top Institutional Investors and Their Stakes

The clear anchor investor is a Brazilian fund manager, which holds a significant portion of the company. This concentration means any decision by this single entity can defintely move the price. Here is a snapshot of the top institutional positions, reflecting data from the 2025 fiscal year filings:

Institutional Investor Shares Held Ownership Percentage Last Reported Date
BSWM Gestão de Recursos Ltda. (via BCM Fund) 322,236 18.4% May 17, 2024
CNBS - Amplify Seymour Cannabis ETF 5,121 N/A Recent 2025 data
Tidal Investments LLC 4,989 0.28% October 31, 2025

The largest stake, held by BSWM Gestão de Recursos Ltda. (as the fund manager for BCM Investimentos Fundo de Investimento Multimercado Crédito Privado Investimento no Exterior, or BCM Fund), represents nearly all the institutional ownership. This is a private fund investment, which often signals a focus on the company's underlying assets and long-term growth potential in the global medicinal cannabis market, rather than short-term trading liquidity.

Recent Changes in Ownership: The Delisting Effect

The most crucial change in Clever Leaves Holdings Inc.'s investor profile wasn't a buy or sell, but the structural shift away from Nasdaq. The company announced its voluntary delisting and SEC deregistration in April 2024, moving its trading to the OTC Markets. This action immediately shrinks the pool of eligible institutional buyers, as many funds have mandates that prohibit holding OTC-listed securities.

Here's the quick math: with a market capitalization of only $5.28 million as of April 3, 2025, and total shares outstanding around 2 million, the stock is firmly in penny-stock territory. This environment attracts a different kind of investor-more speculative and less regulated-which is why the institutional holding value reported by some services is near $0 million.

  • Tidal Investments LLC reported a small decrease of -2.58% in their position as of October 31, 2025.
  • BSWM Gestão de Recursos Ltda.'s position has shown 0% change since its last major filing in May 2024, indicating a stable, committed, but active stake.
  • The overall institutional count is extremely low, with some reports citing only 1 institutional owner filing a 13F or 13D/G.

Impact of Institutional Investors on CLVR's Strategy and Stock

In a company like Clever Leaves Holdings Inc., the impact of institutional investors is two-fold: it drives extreme volatility but also provides a clear strategic alignment. The low float (publicly available shares) combined with low liquidity inherent in OTC trading means that any significant trade, even a small one, can cause massive price swings. You saw this with the erratic, multi-percent daily moves reported in the stock's recent history.

The major institutional player, BCM Fund, holds its stake via a Schedule 13D filing, which is a key distinction. A 13D signals an active investor who intends to influence the company's direction, unlike a passive 13G filer. This active role suggests they are invested in the strategic pivot, which focuses on leveraging the company's low-cost cultivation in Colombia to supply the international pharmaceutical and medicinal markets, a core part of the Mission Statement, Vision, & Core Values of Clever Leaves Holdings Inc. (CLVR).

Their continued holding, despite the delisting, suggests confidence in the company's cost optimization and commercial agreements, like the one with Hypera Pharma in Brazil. This institutional backing, while concentrated, acts as a crucial vote of confidence in the long-term, asset-heavy strategy, even as the stock price remains subject to the whims of low-volume, speculative trading.

Key Investors and Their Impact on Clever Leaves Holdings Inc. (CLVR)

You need to know who is buying Clever Leaves Holdings Inc. (CLVR) and what their moves mean, especially given the stock's volatility. The investor profile is dominated by a few large institutional holders, which gives them a significant, quiet influence on corporate strategy, plus a hefty retail presence.

As of the most recent filings, the ownership structure shows that institutional money, while present, is highly concentrated, with a few firms holding the reins. The total shares outstanding for Clever Leaves Holdings Inc. stands at approximately 1.75 million, with a total market value of about $1.75 million.

Here's the quick math: Other Institutional Investors hold about 36.73% of the company, which is a substantial block of shares, but the largest single slice-62.98%-is held by Public Companies and Retail Investors. That split means the stock is highly susceptible to retail sentiment and momentum swings, plus the strategic direction is heavily influenced by a small number of institutional players.

Notable Institutional Investors and Their Stakes

The institutional landscape for Clever Leaves Holdings Inc. is not a typical roster of massive US-based mutual funds. Instead, you see specialized and international funds taking the top positions, which is common in the global cannabis sector. Two Brazilian-based funds, BCM Investimentos Fundo de Investimento Multimercado Crédito Privado Investimento no Exterior and BSWM Gestão de Recursos Ltda, stand out with identical, large stakes.

These two funds each hold a significant portion of the institutional ownership, reported as 18.36% of the total institutional holding. This concentration means their collective decisions-to hold, sell, or push for change-can defintely move the stock. You should also keep an eye on the exchange-traded fund (ETF) exposure, as passive flows can also drive price action.

  • BCM Investimentos: Holds 322,236 shares, representing 18.36% of the institutional holding.
  • BSWM Gestão de Recursos Ltda: Also holds 322,236 shares, at 18.36%.
  • Amplify Seymour Cannabis ETF (CNBS): A cannabis-focused ETF, holding 5,121 shares.

Investor Influence: Quiet Power in Concentrated Holdings

When a few institutions control a large percentage of the stock, their influence goes beyond just trading volume; it impacts corporate governance and strategic direction. Since BCM and BSWM hold such a concentrated stake, their alignment is crucial for management. They aren't explicitly flagged as activist investors (those filing a Schedule 13D to push for a change), but their sheer size gives them a powerful voice in board appointments, capital allocation, and major strategic shifts, like the company's focus on key markets such as Germany and Brazil.

The presence of a specialized fund like the Amplify Seymour Cannabis ETF also signals that the company is on the radar of cannabis-sector investors, linking its stock performance to broader industry sentiment. If you want to dive deeper into the company's operational strength that underpins these investment decisions, you should check out Breaking Down Clever Leaves Holdings Inc. (CLVR) Financial Health: Key Insights for Investors.

Recent Notable Moves (2025 Fiscal Year)

Looking at the most recent data, institutional activity has been present, even if overall institutional ownership remains a smaller percentage than retail. Tidal Investments LLC, which manages the Amplify Seymour Cannabis ETF, reported its holding of 5,121 shares as recently as August 28, 2025. This is a small but fresh position, indicating continued, albeit minor, institutional interest in the company's cannabinoid and nutraceutical operations.

On the insider front, the picture is one of slight net selling over the past two years. Insiders have sold a total of 2,004 shares for a total value of $5,509.44. While the dollar amount is small, this pattern of insider sales, even minor ones, suggests management is not aggressively accumulating shares at current prices. This is a point to consider when you evaluate the management's conviction in the near-term stock trajectory.

Here is a snapshot of the ownership breakdown based on the most recent filings:

Investor Type Common Stock Held (Shares) % of Shares Outstanding Market Value (Millions)
Other Institutional Investors 644,470 36.73% $0.64
Public Companies & Retail Investors 1,105,409 62.98% $1.11
Mutual Funds & ETFs 5,121 0.29% $0.01
Total 1,755,000 100.00% $1.75

Finance: Monitor the next round of 13F filings (due 45 days after the Q3 2025 calendar end) for any major shifts in the BCM or BSWM positions.

Market Impact and Investor Sentiment

If you're looking at Clever Leaves Holdings Inc. (CLVR), the direct takeaway is this: current investor sentiment is Bearish, but the shareholder structure is highly concentrated in a single large holder. The stock's move to the over-the-counter (OTC) market has dramatically shifted its risk profile, making it a speculation play, not a core investment.

The technical indicators as of November 2025 are defintely pointing down. Out of 24 technical analysis indicators, 0 signal a bullish outlook, while 24 signal a bearish one. This is a clear-cut 'Strong Sell' signal from a purely quantitative perspective. The Fear & Greed Index, a good proxy for market psychology, is sitting at 39, which translates to a state of 'Fear' among traders. This isn't surprising given the company's recent history.

Still, the short interest-the percentage of shares sold short-is remarkably low at just 0.51% of the public float as of October 2025. Here's the quick math: a low short interest ratio suggests that while the general market is pessimistic, professional short-sellers aren't actively betting big on a further collapse. It's a low-float, low-price stock, making it less attractive for high-volume shorting.

Recent Market Reactions and Ownership Structure

The most significant market reaction for Clever Leaves Holdings Inc. in the near-term past was its voluntary delisting from the Nasdaq Stock Market in April 2024. This move, driven by the high costs of compliance and likely future non-compliance with listing requirements, caused the stock to plunge -60% around the time of the announcement. This kind of event permanently re-rates a stock, moving it from a regulated exchange to the more speculative OTC market.

The current ownership breakdown shows a highly concentrated structure, which can lead to sharp price movements on any major block trade. The top three shareholders own 18.86% of the company, with one hedge fund controlling a significant portion.

  • Hedge Funds: Hold 18.4% of shares.
  • General Public: Hold the vast majority at 81.1%.
  • Institutional Investors: Ownership is negligible at 0.284%.

The largest reported shareholder is BSWM Gestão de Recursos Ltda., a hedge fund that holds 18.4% of the company, or 322,236 shares. Their position, last reported in May 2024, is the single most important factor to watch in ownership changes. Any move by a holder of this size will defintely move the price, especially in a low-volume OTC stock.

Analyst Perspectives and 2025 Financial Outlook

Analyst coverage for Clever Leaves Holdings Inc. is extremely limited, which is common for companies that have moved to the OTC market. What this estimate hides, however, is that some financial data points are still being tracked by the market, giving us a forward look at the company's operating health, even if formal analyst ratings are 'Currently not supported.'

For the 2025 fiscal year, the key operational forecasts are focused on core profitability metrics, which strip out non-cash expenses and financing costs. These numbers show a path to positive operational results, which is a key opportunity for a company in a high-growth but capital-intensive sector like global medicinal cannabis. You can read more about the company's business model here: Clever Leaves Holdings Inc. (CLVR): History, Ownership, Mission, How It Works & Makes Money.

Here is a snapshot of the operational financial forecasts for the 2025 fiscal year:

Metric Forecasted 2025 Value Significance
Forecasted Annual EBITDA $26 million Earnings Before Interest, Taxes, Depreciation, and Amortization-a proxy for cash operating profit.
Forecasted Annual EBIT $21 million Earnings Before Interest and Taxes-a measure of profitability from core operations.

The opportunity here lies in the disconnect: a Bearish stock sentiment and near-zero price point versus a projected $26 million in positive EBITDA for the 2025 fiscal year. This suggests that the market is pricing in significant execution risk, or perhaps a high probability of further capital structure changes, despite the positive operational trajectory.

Your action item is clear: Monitor the quarterly earnings releases. The market will react to whether Clever Leaves Holdings Inc. can actually hit that $26 million EBITDA target. Missing it will validate the current bearish sentiment; hitting it could be the catalyst for a significant, albeit volatile, re-rating.

DCF model

Clever Leaves Holdings Inc. (CLVR) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.